Fuhao Chu

1.1k total citations
49 papers, 840 citations indexed

About

Fuhao Chu is a scholar working on Molecular Biology, Complementary and alternative medicine and Pharmacology. According to data from OpenAlex, Fuhao Chu has authored 49 papers receiving a total of 840 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 14 papers in Complementary and alternative medicine and 12 papers in Pharmacology. Recurrent topics in Fuhao Chu's work include Traditional Chinese Medicine Analysis (11 papers), Natural product bioactivities and synthesis (10 papers) and Pharmacological Effects of Natural Compounds (6 papers). Fuhao Chu is often cited by papers focused on Traditional Chinese Medicine Analysis (11 papers), Natural product bioactivities and synthesis (10 papers) and Pharmacological Effects of Natural Compounds (6 papers). Fuhao Chu collaborates with scholars based in China and Macao. Fuhao Chu's co-authors include Haimin Lei, Penglong Wang, Zeqi Su, Xia Ding, Bing Xu, Yu‐Zhong Zhang, Nadia Johnson, Wenqiang Yan, Jie Lin and Yicong Li and has published in prestigious journals such as Scientific Reports, Chemical Engineering Journal and International Journal of Molecular Sciences.

In The Last Decade

Fuhao Chu

45 papers receiving 822 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fuhao Chu China 19 444 206 162 91 82 49 840
Guoyu Li China 19 560 1.3× 204 1.0× 145 0.9× 80 0.9× 54 0.7× 69 1.1k
Dan He China 20 410 0.9× 145 0.7× 116 0.7× 66 0.7× 26 0.3× 70 1.0k
Anuradha Sehrawat United States 22 607 1.4× 162 0.8× 246 1.5× 54 0.6× 90 1.1× 46 1.1k
Chun-Feng Zhang China 21 587 1.3× 315 1.5× 149 0.9× 64 0.7× 87 1.1× 39 1.1k
Pengcheng Wang United States 19 512 1.2× 246 1.2× 148 0.9× 63 0.7× 97 1.2× 39 1.3k
Muobarak J. Tuorkey Egypt 13 386 0.9× 115 0.6× 63 0.4× 69 0.8× 101 1.2× 25 971
Hongwei Fan China 20 421 0.9× 200 1.0× 106 0.7× 69 0.8× 79 1.0× 66 1.1k
Yunliang Zheng China 16 321 0.7× 181 0.9× 162 1.0× 39 0.4× 80 1.0× 47 863
Pengtao You China 16 356 0.8× 122 0.6× 76 0.5× 45 0.5× 103 1.3× 46 823
Zhongxiang Zhao China 23 634 1.4× 251 1.2× 183 1.1× 43 0.5× 101 1.2× 79 1.2k

Countries citing papers authored by Fuhao Chu

Since Specialization
Citations

This map shows the geographic impact of Fuhao Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuhao Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuhao Chu more than expected).

Fields of papers citing papers by Fuhao Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuhao Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuhao Chu. The network helps show where Fuhao Chu may publish in the future.

Co-authorship network of co-authors of Fuhao Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Fuhao Chu. A scholar is included among the top collaborators of Fuhao Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuhao Chu. Fuhao Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Yuqin, Jingyi Jiao, Lei Li, et al.. (2025). Natural small molecule smart hydrogels inhibited the Hsp90/NF‐κB signaling axis in inflammation to achieve sustained antipyretic effect. Journal of Nanobiotechnology. 23(1). 478–478.
2.
Lu, Jihui, Zhenyuan Yang, Ran Xu, et al.. (2025). A self-assembly enzyme-like hydrogel with ROS scavenging and immunomodulatory capability for microenvironment-responsive wound healing acceleration. International Journal of Pharmaceutics. 675. 125529–125529. 2 indexed citations
3.
Li, Tao, Jun Yan, Nadia Johnson, et al.. (2025). Global landscape of hepatic organoid research: A bibliometric and visual study. World Journal of Hepatology. 17(2). 95624–95624. 1 indexed citations
4.
Lin, Jun, Zhongquan Li, Jian Li, et al.. (2025). Da-yuan-yin decoction alleviates bleomycin-induced pulmonary injury by inhibiting epithelial-mesenchymal transition via E-cadherin/β-catenin complex restoration. Journal of Ethnopharmacology. 351. 120148–120148. 1 indexed citations
5.
6.
Zhang, Yaozhi, Zhijia Wang, Xiaoyu Lin, et al.. (2024). Natural polysaccharide hydrogel with bioadhesion characters to synergistically enhance berberine's antibacterial effect by regulating the PTS system of Staphylococcus aureus. International Journal of Biological Macromolecules. 281(Pt 4). 136605–136605. 3 indexed citations
7.
Su, Zeqi, Fuhao Chu, Yuan Li, et al.. (2023). Pharmacodynamics and pharmacological mechanism of Moluodan concentrated pill in the treatment of atrophic gastritis: A network pharmacological study and in vivo experiments. Journal of Ethnopharmacology. 318(Pt A). 116937–116937. 13 indexed citations
8.
Li, Yuan, Tao Li, Haocheng Zheng, et al.. (2022). Manpixiao Decoction Halted the Malignant Transformation of Precancerous Lesions of Gastric Cancer: From Network Prediction to In-Vivo Verification. Frontiers in Pharmacology. 13. 927731–927731. 13 indexed citations
9.
Huang, Xu‐Feng, Zhihua Yuan, Xiaojing Liu, et al.. (2022). Integrative multi-omics unravels the amelioration effects of Zanthoxylum bungeanum Maxim. on non-alcoholic fatty liver disease. Phytomedicine. 109. 154576–154576. 18 indexed citations
10.
Li, Yuan, Fuhao Chu, Ping Li, et al.. (2021). Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification. Journal of Ethnopharmacology. 271. 113854–113854. 64 indexed citations
11.
Chen, Yan, Fuhao Chu, Jie Lin, et al.. (2021). The mechanisms of action of WeiChang'An Pill (WCAP) treat diarrhoea-predominant irritable bowel syndrome (IBS-D) using network pharmacology approach and in vivo studies. Journal of Ethnopharmacology. 275. 114119–114119. 15 indexed citations
12.
13.
14.
Su, Zeqi, Yicong Li, Kaige Liu, et al.. (2020). Dysbiosis of gut microbiota is associated with gastric carcinogenesis in rats. Biomedicine & Pharmacotherapy. 126. 110036–110036. 49 indexed citations
15.
Li, Yicong, Xinbing Sui, Zeqi Su, et al.. (2020). Meta-Analysis of Paclitaxel-Based Chemotherapy Combined With Traditional Chinese Medicines for Gastric Cancer Treatment. Frontiers in Pharmacology. 11. 132–132. 23 indexed citations
16.
Song, Xiaoyu, Yuan Li, Yalei Cao, et al.. (2020). Celastrol inhibits ezrin-mediated migration of hepatocellular carcinoma cells. Scientific Reports. 10(1). 11273–11273. 22 indexed citations
17.
Xu, Bing, Wenqiang Yan, Xin Xu, et al.. (2017). Combination of amino acid/dipeptide with ligustrazine-betulinic acid as antitumor agents. European Journal of Medicinal Chemistry. 130. 26–38. 31 indexed citations
18.
Chu, Fuhao, Wenqiang Yan, Bing Xu, et al.. (2017). Synthesis and biological evaluation of new peroxo-bridged diosgenin derivatives. Chinese Herbal Medicines. 10(1). 54–58. 1 indexed citations
19.
Yang, Yong, Fuhao Chu, Wei-Ru Xu, et al.. (2017). Identification of regulatory role of DNA methylation in colon cancer gene expression via systematic bioinformatics analysis. Medicine. 96(47). e8487–e8487. 17 indexed citations
20.
Li, Guoliang, Kuo Xu, Fuhao Chu, et al.. (2015). Ligustrazinyl amides: a novel class of ligustrazine-phenolic acid derivatives with neuroprotective effects. Chemistry Central Journal. 9(1). 9–9. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guoyu Li Breakdown of academic impact, for papers by Dan He Breakdown of academic impact, for papers by Anuradha Sehrawat Breakdown of academic impact, for papers by Chun-Feng Zhang Breakdown of academic impact, for papers by Pengcheng Wang Breakdown of academic impact, for papers by Muobarak J. Tuorkey Breakdown of academic impact, for papers by Hongwei Fan Breakdown of academic impact, for papers by Yunliang Zheng Breakdown of academic impact, for papers by Pengtao You Breakdown of academic impact, for papers by Zhongxiang Zhao
Rankless by CCL
2026